Cholesterol-rich low density lipoproteins are also more oxidized

Molecular and Cellular Biochemistry

Volumn 355, Issue 1-2, 2011, Pages 187-191

  Lankin, Vadim ^a   Viigimaa, Margus ^b   Tikhaze, Alla ^a   Kumskova, Elena ^a   Konovalova, Galina ^a   Abina, Jelena ^b   Zemtsovskaya, Galina ^b   Kotkina, Tatyana ^a   Yanushevskaya, Elena ^a   Vlasik, Tatyana ^a  

^a INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^b TALLINN UNIVERSITY OF TECHNOLOGY   (Estonia)

Author keywords

Atherosclerosis; Biomarkers; Free radical lipoperoxidation; Malondialdehyde modified low density lipoproteins; Oxidative stress

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; CROSS-SECTIONAL STUDY; ESTONIA; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IMMUNOASSAY; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; RUSSIAN FEDERATION; SCREENING TEST;

ADULT; AGED; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OXIDATION-REDUCTION; RISK FACTORS; YOUNG ADULT;

EID: 80051547389     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-0853-y     Document Type: Article

References (27)

1. Lankin V (2003) The enzymatic systems in the regulation of free radical lipid peroxidation. In: Tomasi A, Ozben T, Skulachev V (eds) Free radicals, nitric oxide, and inflammation: molecular, biochemical, and clinical aspects, vol 344. IOS Press, NATO Science Series, Amsterdam, pp 8-23
2. Lankin V, Tikhaze A (2003) Free radical lipoperoxidation during atherosclerosis and antioxidative therapy of this disease. In: Tomasi A, Ozben T, Skulachev V (eds) Free radicals, nitric oxide, and inflammation: molecular, biochemical, and clinical aspects, vol 344. IOS Press, NATO Science Series, Amsterdam, pp 218-231
3. VZ Lankin AK Tikhaze VI Kapel'ko GS Shepel'kova KB Shumaev OM Panasenko GG Konovalova YuN Belenkov 2007 Mechanisms of oxidative modification of low density lipoproteins under conditions of oxidative and carbonyl stress Biochemistry (Moscow) 72 1081 1090 10.1134/S0006297907100069 1:CAS:528:DC%2BD2sXht1aqsrbE (Pubitemid 350022591)
4. Viigimaa M, Abina J, Zemtsovskaya G, Tikhaze A, Konovalova G, Kumskova E, Lankin V (2010) Malondialdehyde-modified low-density lipoproteins as biomarker for atherosclerosis. Blood Pressure 19:164-168
5. VZ Lankin MO Lisina NE Arzamastseva GG Konovalova LV Nedosugova AI Kaminnyi AK Tikhaze FT Ageev VV Kukharchuk YuN Belenkov 2005 Oxidative stress in atherosclerosis and diabetes Bull Exp Biol Med 140 41 43 16254616 10.1007/s10517-005-0406-z 1:CAS:528:DC%2BD2MXhtVOhu7%2FK (Pubitemid 41548626)
6. LV Nedosugova VZ Lankin MI Balabolkin GG Konovalova MO Lisina KV Antonova AK Tikhaze YuN Belenkov 2003 Interrelation between compensation of carbohydrate metabolism and severity of manifestations of oxidative stress in type II diabetes mellitus Bull Exp Biol Med 136 132 134 14631491 10.1023/A:1026302520288 1:CAS:528:DC%2BD3sXosFWqt7Y%3D (Pubitemid 38132975)
7. VZ Lankin AK Tikhaze VV Kukharchuk GG Konovalova OI Pisarenko AI Kaminnyi KB Shumaev YuN Belenkov 2003 Antioxidants decreases the intensification of low density lipoprotein free radical peroxidation during therapy with statins Mol Cell Biochem 249 129 140 12956408 10.1023/A:1024742907379 1:CAS:528: DC%2BD3sXlsVKlsrs%3D (Pubitemid 37021039)
8. K Liu TE Cuddy GN Piers 1992 Oxidative status of lipoproteins in coronary disease patients Am Heart J 123 285 290 1736561 10.1016/0002-8703(92)90636-A 1:STN:280:DyaK387kt12rtg%3D%3D
9. Kaminnyi AI, Lankin VZ, Perepelitsa EI, Konovalova GG, Samko AN, Tikhaze AK, Kukharchuk VV, Belenkov Yu.N (2007) Relationship between free-radical lipid oxidation and efficiency of coronary angioplasty in coronary patients. Bull Exp Biol Med 140:41-43
10. P Holvoet 1999 Endothelial dysfunction, oxidation of low-density lipoprotein, and cardiovascular disease Therapeutic Apheresis 3 287 293 10608719 10.1046/j.1526-0968.1999.00169.x 1:CAS:528:DC%2BD3cXhvV2qsA%3D%3D
11. D Steinberg 2009 The LDL modification hypotesis of atherogenesis: an update J Lipid Res 50 S376 S381 19011257 10.1194/jlr.R800087-JLR200
12. D Harrison KK Griendling U Landmesser B Hornig H Drexler 2003 Role of oxidative stress in atherosclerosis Am J Cardiol 91 7A 11A 12645638 10.1016/S0002-9149(02)03144-2 1:CAS:528:DC%2BD3sXitVWks7Y%3D (Pubitemid 36351457)
13. H Itabe 2009 Oxidative modification of LDL: its pathological role in atherosclerosis Clinic Rev Allerg Immunol 37 4 11 10.1007/s12016-008-8095-9 1:CAS:528:DC%2BD1MXotl2ns7k%3D
14. NL Irodova VZ Lankin GG Konovalova AG Kochetov IE Chazova 2002 Oxidative stress in patients with primary pulmonary hypertension Bull Exp Biol Med 133 580 582 12447471 10.1023/A:1020238026534 1:CAS:528:DC%2BD38XntFGqsLs%3D (Pubitemid 35345240)
15. NE Arzamastseva VZ Lankin GG Konovalova AK Tikhaze FT Ageev YuV Lapina OYu Narusov VYu Mareev YuN Belenkov 2007 Oxidative stress in patients with chronic heart failure and type II diabetes mellitus Bull Exp Biol Med 143 207 209 17970203 10.1007/s10517-007-0052-8 1:CAS:528:DC%2BD2sXotlSnsrc%3D (Pubitemid 47225374)
16. N Johnston T Jernberg B Lagerqvist A Siegbahn L Wallentin 2006 Improved identification of patients with coronary artery disease by the use of new lipid and lipoprotein biomarkers Am J Cardiol 97 640 645 16490429 10.1016/j.amjcard. 2005.09.123 1:CAS:528:DC%2BD28XhsFGgsr8%3D (Pubitemid 43255031)
17. P Holvoet A Mertens P Verhamme K Bogaerts G Beyens R Verghaeghe D Collen E Muls F Van de Werf 2001 Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease Atheroscler Thromb Vasc Biol 21 844 848 10.1161/01.ATV.21.5.844 1:CAS:528:DC%2BD3MXjs1aitbk%3D (Pubitemid 32448777)
18. J Girona JM Manzaranes F Marimon A Cabre M Heras M Guardiola J Ribalta L Masana 2007 Oxidized to non-oxidized lipoprotein ratios are associated with atherosclerosis and the metabolic syndrome in diabetic patients Nutr Metab Cardiovasc Dis 18 380 387 17904830 10.1016/j.numecd.2007.04.002
19. M Imazu K Ono F Tadehara K Kajiwara H Yamamoto K Sumii N Tasaki J Oiwa Y Shimohara Y Gomyo H Itabe 2008 Plasma levels of oxidized low density lipoprotein are associated with stable angina pectoris and modalities of acute coronary syndrome Int Heart J 49 515 524 18971563 10.1536/ihj.49.515 1:CAS:528: DC%2BD1cXhsVSjurvE
20. Y Ishigaki H Katagiri J Gao T Yamada J Imai K Uno Y Hasegawa K Kaneko T Ogihara H Ishihara Y Sato K Takikawa N Nishimichi H Matsuda T Sawamura Y Oka 2008 Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis Circulation 118 75 83 18559699 10.1161/CIRCULATIONAHA.107.745174 1:CAS:528:DC%2BD1cXnsFKqsrg%3D
21. ER Rietzschei M Langlois ML De Buyzere P Segers D De Bacquer S Bekaert L Cooman P Van Oostveldt P Verdonck GG De Backer TC Gillebert 2008 Oxidized low-density lipoprotein cholesterol is associated with decreases in cardiac function independent of vascular alterations Hypertension 52 535 541 10.1161/HYPERTENSIONAHA.108.114439
22. S Toshima A Hasegawa M Kurabayashi H Itabe T Takano J Sugano K Shimamura J Kimura I Michisita T Suzuki R Nagai 2000 Circulating oxidized lipoprotein levels. A biochemical risk marker for coronary heart disease Atheroscler Thromb Vasc Biol 20 2243 2247 10.1161/01.ATV.20.10.2243 1:CAS:528:DC%2BD3cXptVSisrw%3D
23. T Suzuki H Kohno A Hasegawa S Toshima T Amaki M Kurabayashi R Nagai 2002 Diagnostic implications of circulating oxidized low density lipoprotein levels as a biochemical risk marker of coronary artery disease Clin Biochem 35 347 353 12270763 10.1016/S0009-9120(02)00326-0 1:CAS:528:DC%2BD38Xos1ertbk%3D (Pubitemid 35247942)
24. E Verhoye MR Langlois 2009 Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk Clin Chem Lab Med 47 128 137 19099526 10.1515/CCLM.2009.037 1:CAS:528:DC%2BD1MXislarsL4%3D
25. Compendium of Abridged ESC Guidelines 2010. Springer Healthcare, pp 1-15
26. Countrywide integrated noncommunicable diseases intervention (CINDI) programme. Protocol and guidelines (1996). WHO Regional Office for Europe, Copenhagen
27. V Sigurdardottir B Fagerberg J Hulthe 2002 Circulating oxidized low-density lipoprotein (LDL) is associated with risk factors of the metabolic syndrome and LDL size in clinically healthy 58 year old men (AIR Study) J Int Med 252 440 447 10.1046/j.1365-2796.2002.01054.x 1:CAS:528:DC%2BD38XptVOmsLY%3D (Pubitemid 36706575)